Fundraising Fox

dievini Hopp BioTech holding GmbH & Co. KG

Venture capital

1 people tracked

✨ Fox Verdict
Sign up to see your fit

Investment thesis

dievini backs life and health sciences companies pursuing novel therapeutic and diagnostic approaches with the potential to enable entirely new treatment forms, aiming to give physicians and patients more effective and better-tolerated therapies in mostly life-threatening indications. Portfolio companies focus on oncology, plus neurology, infectious diseases, cell therapy and improved drug formulation. In molecular diagnostics, the emphasis is on personalized-medicine systems and products that improve individual therapy outcomes while reducing side effects. Geographically, dievini concentrates on Germany and Europe while supporting companies in their global development and commercialization.

Source: firm website, verified Aug 3, 2026.

Instruments
Equity

Team Β· 1 people

from the firm's website

Frequently asked questions

What sectors does dievini Hopp BioTech holding GmbH & Co. KG focus on?
dievini Hopp BioTech holding GmbH & Co. KG focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Sector Agnostic.

Similar investors

Featured in lists